TAMPA, FL (PRWEB) March 31, 2004
Anodyne Therapy, LLC these days announced the publication of a fourth peer-reviewed clinical study demonstrating restoration of sensation in the feet of patients with peripheral neuropathy. Also, these patients obtained substantial improvements in ambulation and balance, which led to a 96% reduction in fall rates. This study, conducted at Aurora Medical Center in Denver, Colorado by Alan Kochman, MSPT, appears in the April 2004 issue of Geriatric Physical Therapy.
Prior studies have shown that sensory impairments due to peripheral neuropathy present a significant independent risk for falls that could not be adequately addressed because of the lack of a treatment intervention for the underlying peripheral neuropathy. Prior to receiving Anodyne treatments, the patients with peripheral neuropathy in this study were at high risk for falls based on standardized testing of balance and gait and had experienced an average of three falls throughout preceding 90 days. Soon after obtaining improved foot sensation by way of the use of Anodyne treatments, all patients obtained remarkable increases in ambulation and balance as well as substantial reductions in their fall risk. Actual falls during the 90 days soon after treatment, decreased by 96%.
“We are thrilled with the publication of this additional study in Geriatric Physical Therapy, especially in light of the reported improvements in ambulation and reduction of elderly falls,” said Craig Turtzo, CEO. “One of our previously reported studies had shown considerable improvements in balance when patients with peripheral neuropathy obtained treatments with Anodyne, but the benefits to the patients in this study exceeded our expectations. Other investigators are examining the extent by which Anodyne treatments will reduce the incidence of diabetic foot wounds, an additional significant complication of peripheral neuropathy. We anticipate to soon report decreases in diabetic foot wounds in addition to reductions in elderly falls that had been reported in this study.” Added Mr. Turtzo, “It is very gratifying to be able to boost the lives of patients with peripheral neuropathy, who prior to Anodyne, did not have access to viable treatment alternatives for their condition. Additionally, it appears that we can assist drive down the medical costs typically associated with peripheral neuropathy, which have been estimated to exceed $ 37 billion per year amongst men and women with diabetes alone.”
Anodyne Therapy treatments are at present obtainable nationwide at much more than a thousand outpatient therapy facilities, hospitals, nursing houses, physician offices and property wellness agencies to improve functional outcomes for patients suffering from peripheral neuropathy, chronic discomfort and a broad range of other well being problems. Products are also accessible for convenient property use. For a lot more data, check out http://www.anodynetherapy.com.
Contact Info:
Kim Stebbings
Vice President, Sales and Advertising
Anodyne Therapy, LLC
13570 Wright Circle
Tampa, FL 33626
Office: 813-342-4432 ext. 122
Cell: 720-560-0533
E-mail: kimstebbings@aol.com
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Much more Peripheral Neuropathy Press Releases
No comments:
Post a Comment